Aspiration pneumonia and primary lung abscess: Diagnosis and therapy of an aerobic or an anaerobic infection?

Expert Review of Respiratory Medicine

Volumn 1, Issue 1, 2007, Pages 111-119

  Allewelt, Markus ^a  

^a Hosp Duren Gemeinnutzige GmbH   (Germany)

Author keywords

anaerobic infection; aspiration pneumonia; bacterial infection; lung abscess; pulmonary infection

Indexed keywords

EID: 85013700526     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.1.1.111     Document Type: Article

References (42)

1. Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 68 (4), 560–566 (1975).
2. + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin. Microbiol. Infect. 10 (2), 163–170 (2004).
3. Bartlett JG, Finegold SM. Anaerobic bacterial infection of the lung and pleural space. Am. Rev. Respir. Dis. 110, 56–77 (1974).
4. Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am. J. Med. 56 (2), 202–207 (1974).
5. Marik P, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest 115, 178–183 (1999).
6. El-Solh AA, Pietrantoni C, Bhat A et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am. J. Respir. Crit. Care Med. 167, 1650–1654 (2003).
7. Dore P, Robert R, Grollier G et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am. J. Respir. Crit. Care Med. 153 (4), 1292–1298 (1996).
8. Brook I, Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics 65 (6), 1115–1120 (1980).
9. Grinan NP, Lucena FM, Romero JV, Michavila IA, Dominguez SU, Alia CF. Yield of percutaneous needle lung aspiration in lung abscess. Chest 97, 69–74 (1990).
10. Bartlett JG. The role of anaerobic bacteria in lung abscess. Clin. Infec. Dis. 40, 923–925 (2005).
11. Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest 111, 1266–1272 (1997).
12. Huxley EJ, Viroslav J, Gray WR et al. Pharyngeal aspiration in normal subjects and patients with depressed consciousness. Am. J. Med. 64, 564–586 (1978).
13. Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect. Immun. 68 (7), 3998–4004 (2000).
14. Azoulay-Dupuis E, Mohler J, Bedos JP, Barau C, Fantin B. Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model. Antimicrob. Agents Chemother. 50 (9), 3033–3038 (2006).
15. Smith Hammond CA, Goldstein LB. Cough and aspiration of food and liquids due to oro-pharyngeal dysphagia. Chest 129, S154 –S168 (2006).
16. Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 36, 2756–2763 (2005).
17. Terpenning M. Prevention of aspiration in nursing home patients. Clin. Infect. Dis. 40, 7–8 (2005).
18. Marik P, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 124, 328–336 (2003).
19. Langmore S, Terpenning MS, Schorck A et al. Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia 13, 69–81 (1998).
20. Terpenning M, Taylor G, Lupatin D, Kerr C, Dominguez B, Loesche W. Aspiration pneumonia: dental and oral risk factors in an older veteran population. J. Am. Geriatr. Soc. 49, 557–563 (2001).
21. El-Solh AA, Pietrantoni C, Bhat A. A reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest 126, 1575–1582 (2004).
22. Leibovitz A, Plotnikov G, Habot B, Rosenberg M, Segal R. Pathogenic colonization of oral flora in frail elderly patients fed by nasogastric tube or percutaneous enterogastric tube. J. Gerontol. A Biol. Sci. Med. Sci. 58 (1), 52–55 (2003).
23. Wang JL, Chen KY, Fang CT, Hsueh PR, Yang PC, Chang SC. Changing bacteriology of adult community-acquired lung abscess in Taiwan: Klebsiella pneumoniae versus anaerobes. Clin. Infect. Dis. 40, 915–922 (2005).
24. Ewig S, Schlochtermeier M, Goke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 121 (5), 1486–1492 (2002).
25. Franquet T, Gimenez A, Roson N et al. Aspiration diseases: findings, pitfalls, and differential diagnosis. Radiographics 20, 673–685 (2000).
26. Schulz J. Ueber den lungenabszess und seine chirurgische behandlung. Centralblatt Grenzgebiete Med. Chir. 1 (4), 1–10 (1901).
27. Ott S, Allewelt M, Lorenz J, Reimnitz P, Lode H. A novel approach in the treatment of aspiration pneumonia and primary lung abscess. Presented at: European Respiratory Society 15th Annual Congress. Copenhagen, September 17–21 (2005).
28. Kadowaki M, Demura Y, Mizuno S et al. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest 127 (4), 1276–1282 (2005).
29. Jacobsohn SJ, Griffith K, Diamond S et al. A randomized controlled trial of penicillin vs. clindamycin for the treatemt of aspiration pneumonia in children. Arch. Pediatr. Adolesc. Med. 152 (2), 207–208 (1997).
30. Guidol F, Manresa F, Pallares R et al. Clindamycin vs. penicillin for anaerobic lung infections: high rates of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch. Intern. Med. 150, 2525–2529 (1990).
31. Levison ME, Mangura CT, Lorber B et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann. Intern. Med. 98, 466–471 (1983).
32. Bartlett JG, Gorbach SL. Penicillin or clindamycin for primary lung abscess? Ann. Intern. Med. 98 (4), 546–548 (1983).
33. Fernandez-Sabe N, Carratala J, Dorca J et al. Efficacy and safety of sequential amoxicillin clavulanate in the treatment of anaerobic lung infections. Eur. J. Clin. Microbiol. Infect. 22, 185–187 (2003).
34. Polenakovik H, Burdette SD, Polenakovik S. Moxifloxacin is efficatious for treatment of community acquired lung abscesses in adults. Clin. Infect. Dis. 41, 764–765 (2005).
35. Perlino CA. Metronidazole vs clindamycin treatment of anaerobic pulmonary infection. Failure of metronidazole therapy. Arch. Intern. Med. 141 (11), 1424–1427 (1981).
36. Sanders CV, Hanna BJ, Lewis AC. Metronidazole in the treatment of anaerobic infections. Am. Rev. Respir. Dis. 120 (2), 337–343 (1979).
37. Hirshberg B, Sklair-Levi M, Nir-Paz R, Ben-Sira L, Krivoruk V, Kramer MR. Factors predicting mortality in patients with lung abscess. Chest 115, 746–750 (1999).
38. Wybo I, Piergard D, Verschraegen I et al. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J. Antimicrob. Chemother. 59 (1), 132–139 (2007).
39. Wunderink RG, Rello J, Cammarata SK et al. Linezolid vs vancomycin. Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124, 1789–1797 (2003).
40. Yaqi BH, Zurenko GE. An in vitro time-kill assessment of linezolid and anaerobic bacteria. Anaerobe 9, 1–3 (2003).
41. Livermore D. Linezolid in vitro: mechanism and antibacterial spectrum. J. Antimicrob. Chemother. 51 (Suppl. 2), 9–16 (2003).
42. Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 44, S27 –S72 (2007).